Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Pancreatitis

Free Subscription Articles published in Br J Surg Retrieve available abstracts of 40 articles: HTML format

Single Articles

April 2025
1. ADACHI Y, Okabe H, Hayashi H, Tagayasu Y, et al
   Round ligament coverage with polyglycol acid mesh and fibrin glue on pancreatic stump may decrease postoperative pancreatic fistula in distal pancreatectomy.
   Br J Surg. 2025;112:znaf101.
   PubMed    
   
   
   March 2025
2. HUANG H, Xu D, Huang J
   Laparoscopic spleen-preserving pancreatic tail resection: innovative surgical techniques and strategies.
   Br J Surg. 2025;112:znaf069.
   PubMed    
   
   
   
3. FRANCKEN MFG, Boxhoorn L, van Dijk SM, van Grinsven J, et al
   Cost-effectiveness of immediate versus postponed intervention for infected necrotizing pancreatitis: planned secondary analysis of the POINTER trial.
   Br J Surg. 2025;112:znaf071.
   PubMed    
   
   
   
4. VAN VELDHUISEN CL, Leseman CA, De Rijk FEM, Marques-Antunes J, et al
   Surgery for chronic pancreatitis across Europe (ESCOPA): prospective multicentre study.
   Br J Surg. 2025;112:znaf068.
   PubMed     Abstract available
   
   
   
5. TANAKA H, Sakai A, Suenaga M, Hayashi M, et al
   FUT2 and FUT3-specific normalization of DUPAN-2 and carbohydrate antigen 19-9 in preoperative therapy for pancreatic cancer: multicentre retrospective study (GEMINI-PC-01).
   Br J Surg. 2025;112:znaf049.
   PubMed    
   
   
   
6. LIN H, Ning J, Liu Q, Du X, et al
   Application of transmesocolon pancreatic intestinal anastomosis in duodenal-preserving pancreatic head resection: video article.
   Br J Surg. 2025;112:znaf084.
   PubMed    
   
   
   
7. BONSDORFF A, Kjeseth T, Kirkegard J, de Ponthaud C, et al
   International multicentre validation of the left pancreatectomy pancreatic fistula prediction models and development and validation of the combined DISPAIR-FRS prediction model.
   Br J Surg. 2025;112:znae313.
   PubMed     Abstract available
   
   
   February 2025
8. SHIRAISHI Y, Hayashi H, Liu Z, Schrader J, et al
   YAP/TAZ overexpression activates mTOR and Erk1/2 signalling and is associated with worse outcomes for patients with pancreatic neuroendocrine neoplasms.
   Br J Surg. 2025;112:znaf006.
   PubMed    
   
   
   
9. VAN SANTVOORT H, Voermans RP, Zyromski NJ, Siriwardena AK, et al
   Antibiotic stewardship in acute pancreatitis.
   Br J Surg. 2025;112:znaf007.
   PubMed    
   
   
   
10. WISMANS LV, Hendriks TE, Suurmeijer JA, Nuyttens JJ, et al
    Preoperative stereotactic radiotherapy to prevent pancreatic fistula in high-risk patients undergoing pancreatoduodenectomy (FIBROPANC): prospective multicentre phase II single-arm trial.
    Br J Surg. 2025;112:znae327.
    PubMed     Abstract available
    
    
    
11. DEKKER EN, van Klaveren D, Verkolf EMM, de Wilde RF, et al
    Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort study.
    Br J Surg. 2025;112:znaf011.
    PubMed     Abstract available
    
    
    
12. KLEIVE D
    Reducing pancreatic fistula after left-sided pancreatectomy-the search continues.
    Br J Surg. 2025;112:znaf033.
    PubMed    
    
    
    
13. SUMIYOSHI T, Uemura K, Seo S, Fujii T, et al
    Impact of pre-compression versus non-compression before parenchyma transection in left-sided pancreatic resection on the rate of clinically relevant pancreatic fistula: multicentre randomized clinical trial.
    Br J Surg. 2025;112:znaf008.
    PubMed     Abstract available
    
    
    December 2024
14. DENG Z, Lan Z, Zhu H, Ren H, et al
    Metagenomic next-generation sequencing for the detection of bacterial translocation in the blood of patients following liver, biliary tract or pancreatic surgery.
    Br J Surg. 2024;112:znae326.
    PubMed    
    
    
    October 2024
15. LUCOCQ J, Pandanaboyana S
    Pancreatic cancer arising in intraductal papillary mucinous neoplasms (IPMN): emerging data warrants further research.
    Br J Surg. 2024;111:znae238.
    PubMed    
    
    
    
16. DEKKER EN, Narayan RR, Ahmami MA, Meddouch A, et al
    Chemotherapy switch for localized pancreatic cancer: a systematic review and meta-analysis.
    Br J Surg. 2024;111:znae244.
    PubMed     Abstract available
    
    
    August 2024
17. PARTELLI S, Landoni L, Bartolomei M, Zerbi A, et al
    Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study.
    Br J Surg. 2024;111:znae178.
    PubMed     Abstract available
    
    
    
18. HALLET J, Soreide K
    Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours.
    Br J Surg. 2024;111:znae183.
    PubMed    
    
    
    
19. BRUNA CL, van Hilst J, Esposito A, Kleive D, et al
    The value of splenectomy during left-sided pancreatectomy for pancreatic ductal adenocarcinoma: predefined subanalysis in the DIPLOMA randomized trial.
    Br J Surg. 2024;111:znae236.
    PubMed    
    
    
    
20. SOREIDE K, Barreto SG, Pandanaboyana S
    Severe acute pancreatitis.
    Br J Surg. 2024;111:znae170.
    PubMed    
    
    
    May 2024
21. SISSINGH NJ, de Rijk FEM, Timmerhuis HC, Umans DS, et al
    Gallstones as a cause in presumed acute alcoholic pancreatitis: observational multicentre study.
    Br J Surg. 2024;111:znae107.
    PubMed     Abstract available
    
    
    April 2024
22. UNDERWOOD PW, Cloyd JM
    Comment on: Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
    Br J Surg. 2024;111:znae085.
    PubMed    
    
    
    
23. VAN RAMSHORST TME, van Hilst J, Boggi U, Dokmak S, et al
    Standardizing definitions and terminology of left-sided pancreatic resections through an international Delphi consensus.
    Br J Surg. 2024;111:znae039.
    PubMed    
    
    
    
24. ANDREASI V, Partelli S, Schiavo Lena M, Muffatti F, et al
    Prognostic significance of nodal micrometastases of non-functioning pancreatic neuroendocrine tumours.
    Br J Surg. 2024;111:znae076.
    PubMed    
    
    
    March 2024
25. THEIJSE RT, Stoop TF, Janssen QP, Prakash LR, et al
    Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study.
    Br J Surg. 2024;111:znae033.
    PubMed     Abstract available
    
    
    
26. IMAMURA T, Ashida R, Urakami K, Ohshima K, et al
    Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer.
    Br J Surg. 2024;111:znae059.
    PubMed    
    
    
    January 2024
27. VAN BEEK DJ, Van Den Heede K, Rinkes IB, Norlen O, et al
    Surgery for advanced pancreatic neuroendocrine neoplasms: recommendations based on a consensus meeting of the European Society of Endocrine Surgeons (ESES).
    Br J Surg. 2024;111:znae017.
    PubMed    
    
    
    
28. LARSSON P, Soreide K
    Surgery for oligometastatic pancreatic cancer: next frontier?
    Br J Surg. 2024;111:znad419.
    PubMed    
    
    
    
29. OMIYA K, Maekawa A, Oba A, Inoue Y, et al
    A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of multidisciplinary treatment.
    Br J Surg. 2024;111:znad417.
    PubMed    
    
    
    
30. 
    Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries.
    Br J Surg. 2024;111:znad330.
    PubMed     Abstract available
    
    
    December 2023
31. ONNEKINK AM, Michiels N, Klatte DCF, Oldenburg L, et al
    Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance.
    Br J Surg. 2023 Dec 29:znad430. doi: 10.1093.
    PubMed    
    
    
    
32. HALL LA, Powell-Brett S, Halle-Smith J, Ward L, et al
    Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal surgery: meta-analysis.
    Br J Surg. 2023 Dec 8:znad369. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2023
33. KIRKEGARD J, Ladekarl M, Johannsen IR, Mortensen F, et al
    Effect of adjuvant chemotherapy after pancreatectomy in patients with node-negative pancreatic cancer: target trial emulation.
    Br J Surg. 2023 Nov 25:znad398. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. SCHLAPFER M, Schadde E, Braun J, Soll C, et al
    Effect of volatile versus total intravenous anaesthesia on circulating tumour cells after pancreatic adenocarcinoma resection: multicentre randomized clinical trial.
    Br J Surg. 2023 Nov 14:znad357. doi: 10.1093.
    PubMed    
    
    
    October 2023
35. BOAG KF, Britton E, Knight SR, Coe PO, et al
    Definition and management of intra-abdominal metachronous oligometastatic pancreatic cancer: a systematic review.
    Br J Surg. 2023 Oct 31:znad338. doi: 10.1093.
    PubMed    
    
    
    
36. UMANS DS, Timmerhuis HC, Anten MGF, Bhalla A, et al
    Prospective multicentre study of indications for surgery in patients with idiopathic acute pancreatitis following endoscopic ultrasonography (PICUS).
    Br J Surg. 2023 Oct 9:znad318. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
37. DOPPENBERG D, van Dam JL, Han Y, Bonsing BA, et al
    Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
    Br J Surg. 2023 Jul 13:znad210. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
38. STRAND K, Moller JH
    Fluid treatment in acute pancreatitis: a careful balancing act.
    Br J Surg. 2023 Jun 16:znad155. doi: 10.1093.
    PubMed    
    
    
    
39. MAGGINO L, Malleo G, Crippa S, Belfiori G, et al
    Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy.
    Br J Surg. 2023 Jun 1:znad146. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. AMMER-HERRMENAU C, Lingens CHM, Ratei CS, Heuer C, et al
    Whole 16S rRNA sequencing of the oral microbiome predicts postoperative pancreatic fistula: prospective observational cohort study.
    Br J Surg. 2023 Jun 1:znad129. doi: 10.1093.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.